Neurotech shares jump 25% as chairman speaks of ‘considerable opportunity’ by Steve Jones August 27, 2026August 27, 2026 Shares in drug development firm Neurotech International opened 25% higher today as it spruiked its progress […]
News in brief: Vitura signs MedReleaf deal; Neurotech initiates first site for Phase 3 autism trial by Adam Sheldon March 17, 2026June 8, 2026
Family experience of MC drives Medibis to fund autism anxiety trial by Adam Sheldon August 5, 2025August 19, 2025
Medibis embarks on fresh capital raise ahead of autism clinical trial by Steve Jones February 23, 2024February 28, 2024